abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

这页面没有简体中文版本,现以English显示

文章

2017年4月17日

作者:
Grant Schulte, AP (USA)

USA: Fresenius says Nebraska should not have been able to obtain company's drug for death penalty use

Company: Nebraska shouldn’t have gotten death penalty drug, 13 April 2017

A German pharmaceutical manufacturer whose drugs ended up in Nebraska’s lethal injection supply never intended for state officials to obtain them and tried unsuccessfully to get the corrections department to return them, a company spokesman said Thursday.  Nebraska’s corrections department was only able to buy potassium chloride in 2015 because one of its U.S. distributors made a mistake, said Fresenius Kabi spokesman Matt Kuhn.  His comments came after The Associated Press asked whether company officials were aware that the Nebraska Department of Correctional Services had bought their product for use as a lethal injection drug... 

While the company takes no formal position on capital punishment, it requires distributors to sign an agreement promising not sell certain drugs to state corrections departments.  “Our products are developed and approved solely for patient care, and we expressly restrict the sale of our products for use in lethal injection,” he said.

The American Civil Liberties Union of Nebraska, a leading critic of capital punishment, called on lawmakers to reject the push for secrecy and launch an investigation.  “These shocking allegations are just the latest illustration of how Nebraska’s death penalty is broken beyond repair,” said Danielle Conrad, the group’s executive director. The company’s statement “underscores the need to honor Nebraska’s strong tradition of open government and the need to ensure transparency in the death penalty process.”

Death penalty supporters said companies shouldn’t dictate how their products are used once they’re sold and blamed anti-death penalty activists for pressuring companies to stop selling drugs with legitimate medical purposes...

Robert Dunham, executive director of the Death Penalty Information Center,...said many pharmaceutical companies are worried about negative publicity and economic consequences in addition to moral concerns about the death penalty. [also refers to Mylan, Naari]

隐私资讯

本网站使用 cookie 和其他网络存储技术。您可以在下方设置您的隐私选项。您所作的更改将立即生效。

有关我们使用网络存储的更多信息,请参阅我们的 数据使用和 Cookie 政策

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

分析 cookie

ON
OFF

您浏览本网页时我们将以Google Analytics收集信息。接受此cookie将有助我们理解您的浏览资讯,并协助我们改善呈现资讯的方法。所有分析资讯都以匿名方式收集,我们并不能用相关资讯得到您的个人信息。谷歌在所有主要浏览器中都提供退出Google Analytics的添加应用程式。

市场营销cookies

ON
OFF

我们从第三方网站获得企业责任资讯,当中包括社交媒体和搜寻引擎。这些cookie协助我们理解相关浏览数据。

您在此网站上的隐私选项

本网站使用cookie和其他网络存储技术来增强您在必要核心功能之外的体验。